Comparative Analysis of Hematological, Biochemical, and Inflammatory Biomarkers in Malaria and Dengue Patients in an Endemic Setting of Pakistan
This hospital-based cross-sectional study in District Swat, Pakistan, reveals that while platelet counts and inflammatory ratios do not differ significantly, dengue patients exhibit distinctively higher hemoglobin, hematocrit, blood urea, creatinine, and ALT levels compared to malaria patients, suggesting these routine biochemical and hematological parameters can effectively support early clinical differentiation in resource-constrained settings.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the warm, humid regions of the world, two mosquito-borne diseases often arrive together, bringing fever, chills, and a deep sense of illness that can strike anyone at any time. Malaria, caused by a microscopic parasite, and dengue, caused by a virus, are both notorious for their ability to spread rapidly in areas where standing water allows mosquitoes to breed. For a doctor in a busy clinic, the challenge is immediate and difficult: both illnesses start with nearly identical symptoms. A patient arrives with a high fever, a pounding headache, and body aches. Without a specialized laboratory test, it is nearly impossible to tell which enemy is at work just by looking at the person. This distinction matters deeply because the treatments and the risks are different; one disease involves the body leaking fluid, while the other involves the destruction of red blood cells. In places where advanced medical equipment is scarce, finding a way to tell them apart using simple, routine blood tests could save lives by guiding doctors to the right care much sooner.
Researchers in the Swat district of Pakistan, a region where both diseases are common, set out to solve this puzzle by comparing the blood of patients who had been confirmed to have either malaria or dengue. They gathered blood samples from 110 people—55 with malaria and 55 with dengue—who had arrived at local hospitals. The team looked at a wide range of standard measurements, including the number of blood cells, the levels of proteins and enzymes, and the ratio of different types of white blood cells that fight infection. Their goal was to see if any of these routine numbers could act as a reliable signpost to distinguish the two diseases without needing expensive or complex testing.
The study revealed a clear and surprising pattern in the blood of the patients. Those with dengue had significantly higher levels of hemoglobin and hematocrit, which are measures of the red blood cells that carry oxygen. In simple terms, the blood of dengue patients was thicker and more concentrated. This happens because dengue causes tiny blood vessels to leak fluid into the surrounding tissues, leaving the red blood cells behind in a smaller volume of liquid. In contrast, the patients with malaria had lower levels of these same markers. This makes sense because the malaria parasite attacks and destroys red blood cells, leading to a thinner, more diluted blood supply. The difference was so distinct that the researchers found it to be one of the most powerful ways to tell the two illnesses apart.
Beyond the red blood cells, the researchers found that the dengue patients also showed signs of stress in their kidneys and liver. Their blood contained higher amounts of urea and creatinine, substances that the kidneys usually filter out, suggesting the kidneys were struggling to keep up with the body's needs. They also had much higher levels of an enzyme called ALT, which is released when liver cells are damaged. These findings align with what is known about dengue, which is known to target the liver and cause fluid loss that strains the kidneys. On the other hand, the malaria patients did not show these specific spikes in kidney and liver markers to the same degree. The total bilirubin, a yellow pigment that can rise in both conditions, did not help distinguish between the two, as it remained similar in both groups.
Interestingly, the study found that some of the markers doctors often rely on were not helpful in this specific setting. The total number of white blood cells and the number of platelets, which help blood clot, were surprisingly similar in both groups. In many other parts of the world, a low platelet count is a classic sign of dengue, but by the time these patients reached the hospital in Swat, both diseases had caused similar drops in platelets, making that number useless for telling them apart. The researchers also looked at the ratios of different types of white blood cells, such as the neutrophil-to-lymphocyte ratio, which some previous studies suggested could be a quick way to differentiate the diseases. However, in this group of patients, those ratios were almost identical for both malaria and dengue, showing no ability to separate the two conditions.
The researchers noted that the patients with dengue were, on average, about ten years older than those with malaria, which is a factor that can influence blood chemistry. They acknowledged that this age difference might have contributed slightly to the higher kidney and liver numbers seen in the dengue group, but the size of the differences was so large that the disease itself was clearly the main driver. The study concludes that in this region, the most useful tools for a doctor to distinguish between malaria and dengue are the simple measures of red blood cell concentration and the levels of kidney and liver stress markers. While the total count of blood cells and the specific ratios of white blood cells did not provide a clear answer, the combination of thicker blood and elevated liver and kidney enzymes points strongly toward dengue, while thinner blood points toward malaria. These findings offer a practical path forward for doctors in resource-limited settings, suggesting that the standard blood tests already available in most hospitals can be used to make better, faster decisions about patient care.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.